SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601830-23-000075
Filing Date
2023-12-15
Accepted
2023-12-15 08:41:13
Documents
14
Period of Report
2023-12-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxrx-20231215.htm   iXBRL 8-K 24333
2 EX-5.1 exhibit51-wsgropinion.htm EX-5.1 11447
6 image_1.jpg GRAPHIC 68421
  Complete submission text file 0001601830-23-000075.txt   259446

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20231215.xsd EX-101.SCH 1907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20231215_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20231215_pre.xml EX-101.PRE 13047
8 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20231215_htm.xml XML 2746
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 231488905
SIC: 2836 Biological Products, (No Diagnostic Substances)